FK506 increases pigmentation and migration of human melanocytes

British Journal of Dermatology

Volumn 155, Issue 5, 2006, Pages 1037-1040

  Kang, H Y ^a   Choi, Y M ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

FK506; Melanocyte; Migration; Pigmentation; Tacrolimus

Indexed keywords

MELANIN; MONOPHENOL MONOOXYGENASE; TACROLIMUS;

ARTICLE; ASSAY; BOYDEN CHAMBER ASSAY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; COULTER COUNTER; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOCYTE; MELANOGENESIS; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCRATCH ASSAY; SKIN PIGMENTATION; VITILIGO;

CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; MALE; MELANINS; MELANOCYTES; MONOPHENOL MONOOXYGENASE; PIGMENTATION; TACROLIMUS;

EID: 33749857796     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07467.x     Document Type: Article

References (10)

1. Travis LB, Weinberg JM, Silverberg NB. Successful treatment of vitiligo with 0.1% tacrolimus ointment. Arch Dermatol 2003; 139:571-4.
2. Skaehill PA. Tacrolimus in dermatologic disorders. Ann Pharmacother 2001; 35:582-8.
3. Grimes PE, Morris R, Avaniss-Aghajani E et al. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 2004; 51:52-61.
4. Lan CC, Chen GS, Chiou MH et al. FK506 promotes melanocyte and melanoblast growth and creates a favorable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Br J Dermatol 2005; 153:498-505.
5. Gordon-Thomson C, Jones J, Mason RS et al. ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells. Melanoma Res 2005; 15:21-8.
6. Karashima T, Hachisuka H, Sasai Y. FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the G0/G1 phases of the cell cycle. J Dermatol Sci 1996; 12:246-54.
7. Kaplan A, Matsue H, Shibaki A et al. The effects of cyclosporin A and FK506 on proliferation and IL-8 production of cultured human keratinocytes. J Dermatol Sci 1995; 10:130-8.
8. Tiefenthaler M, Hofer S, Ebner S et al. In vitro treatment of dendritic cells with tacrolimus: impaired T-cell activation and IP-10 expression. Nephrol Dial Transplant 2004; 19:553-60.
9. Fricain JC, Sibaud V, Campana F et al. Mucosal pigmentation after oral lichen planus treatment with topical tacrolimus. Dermatology 2005; 210:229-32.
10. Hickey JR, Robson A, Barker JN et al. Does topical tacrolimus induce lentigines in children with atopic dermatitis? A report of three cases. Br J Dermatol 2005; 152:152-4.